Mineral fibre analysis and routes of exposure to asbestos in the development of mesothelioma in an English region

Occupational and Environmental Medicine

Volumn 56, Issue 1, 1999, Pages 51-58

  Howel, Denise ^a,f   Gibbs, Allen ^b   Arblaster, Lorna ^c   Swinburne, Layinka ^d   Schweiger, Martin ^e   Renvoize, Edward ^e   Hatton, Paul ^e   Pooley, Frederick ^e  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NATIONAL HEALTH SERVICE   (United Kingdom)

^c UNIVERSITY OF LEEDS   (United Kingdom)

^d ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^e Leeds Healthcare ^*

^f NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Asbestos; Fibre retention; Mesothelioma

Indexed keywords

ASBESTOS; ASBESTOS FIBER;

ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; HUMAN; HUMAN TISSUE; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; MESOTHELIOMA; NORMAL HUMAN; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; UNITED KINGDOM;

EID: 0032940306     PISSN: 13510711     EISSN: None     Source Type: Journal    
DOI: 10.1136/oem.56.1.51     Document Type: Article

References (38)

1. Mowe G, Gylseth B, Hartveit F, et al. Fiber concentration in lung tissue of patients with malignant mesothelioma: a case-control study. Cancer 1985;56:1089-93.
2. Rogers AJ, Leigh J, Berry G, et al. Relationship between lung asbestos fiber type and concentration and relative risk of mesothelioma. A case-control study. Cancer 1991;67:1912-20.
3. Tuomi T, Huuskonen MS, Virtamo M, et al. Relative risk of mesothelioma associated with different levels of exposure to asbestos. Scand J Work Environ Health 1991;17:404-8.
4. McDonald JC, Armstrong B, Case B, et al. Mesothelioma and asbestos fiber type. Evidence from lung tissue analyses. Cancer 1989;63:1544-7.
5. Gaudichet A, Janson X, Monchaux G. Assessment by analytical microscopy of the total lung fibre burden in mesothelioma patients matched with four other pathological series. Ann Occup Hyg 1988;32(supp 1):213-23.
6. Arblaster L, Hatton P, Howel D, et al. Occupational and environmental links to mesothelioma deaths occuring in Leeds during 1971-87. J Public Health Med 1995;17:297-304.
7. Howel D, Arblaster L, Swinburne L, et al. Routes of asbestos exposure and the development of mesothelioma in an English region. Occup Environ Med 1997;54:403-9.
8. Gibbs AR, Pooley FD. Analysis and interpretation of inorganic mineral particles in lung tissues. Thorax 1996;51:327-34.
9. Pooley FD, Clarke NJ. Quantitative assessment of inorganic fibrous particles in dust samples with an analytic electron microscope. Ann Occup Hyg 1979;22:253-71.
10. Collett D. Modelling binary data. London: Chapman and Hall, 1991.
11. Cuzick J. A Wilcoxon-type test for trend. Stat Med 1985;4:87-90.
12. Gibbs AR. Role of asbestos and other fibres in the development of diffuse malignant mesothelioma. Thorax 1990;45: 649-54.
13. Gibbs AR, Jones JSP, Pooley FD, et al. Non-occupational malignant mesotheliomas. In: Bignon J, Peto J, Saracci R, eds. Non-occupational exposures to mineral fibres. Lyon: IARC, 1989:219-28.
14. Srebro SH, Roggli VL, Samsa GP. Malignant mesothelioma associated with low pulmonary tissue asbestos burdens: a light and scanning electron microscopic analysis of 18 cases. Mod Pathol 1995;8:614-21.
15. Baris YI, Simonato L, Artvinli M, et al. Epidemiological and environmental evidence of the health effects of exposure to erionite fibres: a four year study in the Cappadocian region of Turkey. Int J Cancer 1987;39:10-17.
16. Peterson JT, Greenberg SD, Buffler PA. Non-asbestos related malignant mesothelioma. Cancer 1984;54:951-60.
17. Pepper C, Jasani B, Navabi H, et al. Simian virus 40 large T antigen (SV40LTAg) primer specific DMNA amplification in human pleural mesothelioma tissue. Thorax 1996;51:1074-6.
18. McDonald JC, McDonald AD. The epidemiology of mesothelioma in historical context. Eur Respir J 1996;9:1932-42.
19. Wagner JC, Sleggs CA, Marchand P. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med 1960;17:260-71.
20. Newhouse ML, Thompson H. Mesothelioma of the pleura and peritoneum following exposure to asbestos in the London area. Br J Ind Med 1965;22:261-9.
21. Hain E, Dalquen P, Bohlig H, et al. Catamnestic investigations of the origins of mesothelioma. Internationales Archiv fur Arbeitsmedizin 1974;33:15-37.
22. Wagner JC, Newhouse ML, Corrin B, et al. Correlation between fibre content of the lung and disease in east London asbestos factory workers. Br J Ind Med 1988;45:305-8.
23. Acheson ED, Gardner MJ, Pippard EC, et al. Mortality of two groups of women who manufactured gas masks from chrysotile and crocidolite asbestos. Br J Ind Med 1982;39:344-8.
24. Takahashi K, Case BW, Dufresne A, et al. Relation between lung asbestos fibre burden and exposure indices based on job history. Occup Environ Med 1994;51:461-9.
25. Sebastien P, McDonald JC, McDonald AD, et al. Respiratory cancer in chrysotile textile and mining industries: exposure inferences from lung analysis. Br J Ind Med 1989; 46:180-7.
26. Wagner JC, Moncrieff CB, Coles R, et al. Correlation between fibre content of the lungs and disease in naval dockyard workers. Br J Ind Med 1986;43:391-5.
27. Albin M, Johansson L, Pooley FD, et al. Mineral fibres, fibrosis, and asbestos bodies in lung tissue from deceased asbestos cement workers. Br J Ind Med 1990;47:767-74.
28. Tuomi T, Huuskonen MS, Tammileto L, et al. Occupational exposure to asbestos as evaluated from work histories and analysis of lung tissues from patients with mesothelioma. Br J Ind Med 1991;48:48-52.
29. Tossavainen A, Karjalainen A, Karhunen PJ. Retention of asbestos fibres in the human body. Environ Health Perpect 1994;102(suppl 5):253-5.
30. Gibbs AR, Griffiths DM, Pooley FD, et al. Comparison of fibre types and size distributions in lung tissues of paraoccupational and occupational cases of malignant mesothelioma. Br J Ind Med 1990;47:621-6.
31. Case BW. Biological indicators of chrysotile exposure. Ann Occup Hyg 1994;38:503-18.
32. Churg A. Analysis of lung asbestos content. Br J Ind Med 1991;48:649-52.
33. Churg A, Wood P. Observations on the distribution of asbestos fibres in human lungs. Environ Res 1983;31:374-80.
34. Jones JSP, Pooley FD, Sawle GW, et al. The consequences of exposure to asbestos dust in a war time gas mask factory. In: JC Wagner, ed. Biological effects of mineral fibres. Lyon: IARC Scientific Publications, 1980:637-53.
35. Wagner JC, Pooley FD, Berry G, et al. A pathological and mineralogical study of asbestos-related deaths in the United Kingdom in 1977. Ann Occup Hyg 1982;26:423-31.
36. McDonald AD, McDonald JC, Pooley FD. Mineral fibre content of lung in mesothelial tumours in North America. Ann Occup Hyg 1982;26:417-22.
37. Churg A, Wiggs B, DePaoli L, et al. Lung asbestos content in chrysotile workers with mesothelioma. Am Rev Respir Dis 1984;130:1042-5.
38. Dufresne A, Begin R, Churg A, et al. Mineral fibre content of lungs in patients with mesothelioma seeking compensation in Quebec. Am J Respir Crit Care Med 1996;153:711-18.